IndraLab

Statements


HDAC4 inhibitor inhibits HCN1. 1 / 1
| 1

reach
"Valproic acid (VPA), a HDAC4 inhibitor, could reverse the decreased HCN1 and protect neuron damage from OGD/R injury."